|
Fifth Dimension Site Map Search Contact Us |
|
|
Diet and Cancer Survivorship References |
1. Trends in Intake of Energy and Macronutrients - United States, 1971--2000,
CDC Morbidity and Mortality Weekly Report 2/6/04.
2. Popkin et al., Obesity Nov 2007.
3. Kushi et al. CA Cancer J Clin 2006;56:254-281.
4. Ries et al. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National
Cancer Institute, 2006.
5. Emmons, et. al., 2002
6. Maunsell, et. al., 2002
7. Courney, A., et. al., 2000.
8. JAMA 3/21/07
9. Meyerhardt
10. Freudenheim, J.L., Marshall, J.R., Vena, J.E., Laughlin, R., Brasure, J.R., Swanson,
M.K., et al. (1996). Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. Journal of the National Cancer Institute, 88, 340-348.
11. Rock, Cl., Saxe, G.A., Ruffin, M.T. 4th, August, D.A, & Schottenfeld, D. (1996).
Carotenoids, vitamin A, and estrogen receptor status in breast cancer. Nutrition and Cancer,25(3), 281-296.
12. Eastwood, M.A. (1999). Interaction of dietary antioxidants in vivo: How fruit and
vegetables prevent disease? Quarterly Journal of Medicine, (92), 527-530.
13. Voorrips, L.E., Goldbohm, R.A., Brants, H.A., van Poppel, G.A., Sturmans, F., Hermus, R.J.,
et al. (2000). A prospective cohort study on antioxidant and folate intake and male lung cancer risk. Cancer Epidemiology Biomarkers and Prevention, 9, 357-365.
14. Hodge, A.M., English, D.R., McCredie, M.R., Severi, G., Boyle, P., Hopper, J.L., et
al. (2004). Foods, nutrients and prostate cancer. Cancer Causes Control, 15(1), 11-20.
15. Fruits and Vegetables, vol. 8, Lyon, France, International Agency for Research on
Cancer, World Health Organization, 2003.
16. Rock, C.L., Flatts, W., Natarajan, L., et. al., Plasma Carotenoids and Recurrence-
Free Survival in Women with a History of Breast Cancer, J Clin Onc, 2005; 23: 6631-6638.
17. Pierce et al. JCO 2007
18. Trichopoulou et al. N Engl J Med 2003;7:407-22
19. Agudo A, Cabrera L, Amiano P, Ardanaz E, Barricarte A, Berenguer T, Chirlaque MD, Dorronsoro M, Jakszyn P, Larranaga N, Martinez C, Navarro C, Quiros JR, Sanchez MJ, Tormo MJ, Gonzalez CA. Fruit and vegetable intakes, dietary antioxidant nutrients, and total mortality in Spanish adults: findings from the Spanish cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Spain).
Am J Clin Nutr. 2007 Jun;85(6):1634-42.
20. Pierce, J.P., Faerber, S., Wright, F.A., Rock, C.L., Newman, V., Flatt, S.W., et al.
(2002). A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study.
Controlled Clinical Trials, 23(6), 728-756.
21. Wellness Letter, UC Berkeley; 24(6), March 2008.
22. Pelucchi C, Talamini R, Galeone C, Negri E, Franceschi S, Dal Maso L, et al. Fibre
intake and prostate cancer risk. Intl J Cancer. 2004;109(2):278-280.
23. Tymchuk CN, Barnard RJ, Heber D, Aronson WJ. Evidence of an inhibitory effect of diet and exercise on prostate cancer cell growth. J Urol. 2001;166(3):1185-1189.
24. Hebert JR, Hurley TG, Olendzki BC, Teas J, Ma Y, Hampl JS, et al. Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J Natl Cancer Inst. 1998;90:1637-1647.
25. Harris, P.J., Roberton, A.M., Watson, M.E., Triggs, C.M., & Ferguson, L.R. (1993).
The effects of soluble-fiber polysaccharides on the adsorption of a hydrophobic
carcinogen to an insoluble dietary fiber. Nutrition and Cancer, 19(1), 43-54.
26. (Health and Nutrition Letter from Tufts, August 2007, vol. 5, #6, pg. 1, 2.)
27. Adebamowo CA, Cho E, Sampson L, Katan MB, Spiegelman D, Willett WC, et al.
Dietary flavonols and flavonol-rich foods intake and the risk of breast cancer. Int
J Cancer 2005;114(4):628-633.
28. (Cade et al. Int J Epidemiol. 2007 Apr;36(2):431-8
29. (McEligot et al., Nutr Cancer. 2006;55(2):132-40)
30. Slavin JL. Mechanisms for the impact of whole grain foods on cancer risk. J Am Coll Nutr. 2000;19(3 Suppl):300S-307S.
31. Slavin J. Why whole grains are protective: biological mechanisms. Proc Nutr Soc.
2003;62(1):129-134.
32. Rock CL, Flatt SW, Thomson CA, Stefanick ML, Newman VA, Jones LA, et al.
Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer. J Clin Oncol. 2004;22(12):2379-2387.
33. Ferreres F, Valentao P, Llorach R, Pinheiro C, Cardoso L, Pereira JA, et al. Phenolic
compounds in external leaves of tronchuda cabbage (Brassica oleracea L. var.
costata DC). J Agric Food Chem. 2005;53(8):2901-2907.
34. Romieu I, Lazcano-Ponce E, Sanchec-Zamorano LM, Wilett W, Hernandez-Avila M.
Carbohydrates and the risk of breast cancer among Mexican women. Cancer Epidemiol Biomarkers Prev. 2004;13(8):1283-1289.
35. Tavani A, Giordano L, Gallus S, Talamini R, Franceschi S, Giacosa A, et al.
Consumption of sweet foods and breast cancer risk in Italy. Ann Oncol. 2005 Oct 25. [Epub ahead of print]
36. Nkondjock A, Ghardirian P. Intake of specific carotenoids and essential fatty acids
and breast cancer risk in Montreal, Canada. Am J Clin Nutr. 2004;79(5):857-864.
37. Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, Schunemann HJ, et al. Fasting
glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev. 2002;11(11):1361-1368.
38. Grimberg A. Mechanisms by which IGF-I May Promote Cancer. Cancer Biol Ther.
2003;2(6):630-635.
39. Venkateswaran V, Haddad AQ, Fleshner NE, Fan R, Sugar LM, Nam R, Klotz LH,
Pollak M. Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts. J Natl Cancer Inst. 2007;99(23):1793-1800.
40. Dewell A, Weidner G, Sumner MD, Barnard RJ, Marlin RO, Daubenmier JJ, Chi C,
Carroll PR, Ornish D. Relationship of dietary protein and soy isoflavones to serum IGF-1 and IGF binding proteins in the Prostate Cancer Lifestyle Trial. Nutr Cancer. 2007;58(1):35-42.
41. Nowell S, Ratnasinghe DL, Ambrosone CB, Williams S, Teague-Ross T, Trimble L, et al. Association of SULT1A1 Phenotype and Genotype with Prostate Cancer Risk in African-Americans and Caucasians.
Cancer Epidemiol Biomarkers Prev. 2004;13(2):270-276.
42. Hu JJ, Hall MC, Grossman L, Hedayati M, McCullough DL, Lohman K, et al. Deficient nucleotide excision repair capacity enhances human prostate cancer risk. Cancer Res. 2004;64(3):1197-1201.
43. Ferguson LR. Meat consumption, cancer risk and population groups within New Zealand. Mutation Res. 2002;506-507:215-224.
44. Koutros S, Cross AJ, Sandler DP, Hoppin JA, Ma X, Zheng T, Alavanja MC, Sinha R Meat and meat mutagens and risk of prostate cancer in the agricultural health study. Cancer Epidemiol Biomarkers Prev. 2008;17(1):80-87.
45. (Kushi et al. CA Cancer J Clin 2006;56:254-281)
46. Hu et al. Meat and fish consumption and cancer in Canada. Nutr Cancer. 2008
May;60(3):313-24)
47. (Pierce, JAMA 2007)
48. (Chlebonski) WINS Trial
49. Chan et al. Cancer Causes Control. 2007 Dec;18(10):1153-67
50. Nothlings U, Wilkens LR, Murphy SP, Hankin JH, Henderson BE, Kolonel LN. Meat
and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study. J
Natl Cancer Inst. 2005;97(19):1458-1465.
51. Qiu JL, Chen K, Zheng JN, Wang JY, Zhang LJ, Sui LM. Nutritional factors and
gastric cancer in Zhoushan Islands, China. World J Gastroenterol. 2005;11(28):4311-4316.
52. Gonzalez CA, Navarro C, Martinez C, Quiros JR, Dorronsoro M, Barricarte A, et al.
[The European prospective investigation about cancer and nutrition (EPIC)] [Article in Spanish] Rev Esp Salud Publica 2004;78(2):167-176.
53. Alothaimeen A, Ezzat A, Mohamed G, Muammar T, Al-Madouj A. Dietary fat and
breast cancer in Saudi Arabia: a case-control study. East Mediterr Health J. 2004;10(6):879-886.
54. Michaud, D.S., Augustsson, K., Rimm, E.B., Stampfer, M.J., Willett, W.C.,
Giovannucci, E., et al. (2001). A prospective study on intake of animal products and risk of prostate cancer. Cancer Causes Control, 12(6), 557-567
55. Voorrips LE, Brants HA, Kardinaal AF, Kiddink GJ, van den Brandt PA, Goldbohm
RA. Intake of conjugated linoleic acid, fat, and other fatty acids in relation to postmenopausal breast cancer: the Netherlands Cohort Study on Diet and Cancer. Am J Clin Nutr. 2002;76(4):873-882.
56. Rissanen H, Knekt P, Jarvinen R, Salminen I, Hakulinen T. Serum fatty acids and
breast cancer incidence. Nutr Cancer 2003;45(2):168-175.
57. Kohlmeier L, Simonsen N, van't Veer P, Strain JJ, Martin-Moreno JM, Margolin B,
et al. Adipose tissue trans fatty acids and breast cancer in the European Community Multicenter Study on Antioxidants, Myocardial Infarction, and Breast Cancer. Cancer Epidemiol Biomarkers Prev. 1997;6(9):705-710.
58. Bakker, N., Van't, Veer, P., & Zock, P.L. (1997). Adipose fatty acids and cancers of
the breast, prostate and colon: an ecological study. EURAMIC Study Group. International Journal of Cancer, 72(4), 587-591.
59. Slattery, M.L., Benson, J., Ma, K.N., Schaffer, D., & Potter, J.D. (2001). Trans-fatty
acids and colon cancer. Nutrition and Cancer, 39(2), 170-175.
60. Ritch CR, Wan RL, Stephens LB, Taxy JB, Huo D, Gong EM, Zagaja GP, Brendler CB. Dietary fatty acids correlate with prostate cancer biopsy grade and volume in Jamaican men. J Urol. 2007;177(1):97-101.
61. Simopoulos et al. The importance of the omega-6/omega-3 fatty acid ratio in
cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood). 2008 Apr 11 [Epub ahead of print]
62. Maillard V, Bougnoux P, Ferrari P, Jourdan ML, Pinault M, Lavillonniere F, et al. N-
3 and N-6 fatty acids in breast adipose tissue and relative risk of breast cancer in a
case-control study in Tours, France. Int J Cancer 2002;98(1):78-83.
63. Bagga D, Anders KH, Wang HJ, Glaspy JA. Long-chain n-3-to-n-6 polyunsaturated
fatty acid ratios in breast adipose tissue from women with and without breast cancer. Nutr Cancer 2002;42(2):180-185.
64. Berquin IM, Min Y, Wu R, Wu J, Perry D, Cline JM, Thomas MJ, Thornburg T, Kulik G, Smith A, Edwards IJ, D'Agostino R, Zhang H, Wu H, Kang JX, Chen YQ. Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids. J Clin Invest. 2007;117(7):1866-1875.
65. Hughes-Fulford M, Li CF, Boonyaratanakornkit J, Sayyah S. Arachidonic acid activates phosphatidylinositol 3-kinase signaling and induces gene expression in prostate cancer. Cancer Res. 2006;66(3):1427-1433.
66. Saadatian-Elahi M, Norat T, Goudable J, Riboli E. Biomarkers of dietary fatty acid
intake and the risk of breast cancer: a meta-analysis. Int J Cancer
2004;111(4):584-591.
67. Rose DP, Connolly JM. Effects of fatty acids and eicosanoid synthesis inhibitors on
the growth of two human prostate cancer cell lines. Prostate 1991;18(3):243-254.
68. Davis BC, Kris-Etherton PM. Achieving optimal essential fatty acid status in
vegetarians: current knowledge and practical implications. Am J Clin Nutr. 2003;78(3 Suppl):640S-646S.
69. Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A. Dietary long-chain n-3 fatty
acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr.
2004;79(6):935-945.
70. Gago-Dominguez M, Yuan JM, Sun CL, Lee HP, Yu MC. Opposing effects of
dietary n-3 and n-6 fatty acids on mammary carcinogenesis: The Singapore Chinese Health Study. Br J Cancer 2003;89(9):1686-1692.
71. Hodge AM, English DR, McCredie MR, Severi G, Boyle P, Hopper JL, et al. Foods, nutrients and prostate cancer. Cancer Causes Control. 2004;15(1):11-20.
72. Wolk A, Bergstrom R, Hunter D, Willett W, Ljung H, Holmberg L, et al. A
prospective study of association of monounsaturated fat and other types of fat
with risk of breast cancer. Arch Intern Med. 1998;158(1):41-45.
73. Solanas M, Hurtado A, Costa I, Moral R, Menendez JA, Colomer R, et al. Effects of a
high olive oil diet on the clinical behavior and histopathological features. Breast Cancer Research and Treatment
74. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, et al.
Hypovitaminosis D in medical inpatients. New Engl J Med. 1998;338:777-778.
75. Rasmussen LB, Hansen GL, Hansen E, Koch B, Mosekilde L, Molgaard C, et al. Vitamin D: should the supply in the Danish population be increased? Intl J Food Sci Nutr. 2000;51(3):209-215.
76. Webb AR, Pilbeam C, Hanafin N, Holick MF. An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Amer J Clin Nutr. 1990;51:1075--1081.
77. Silverberg SJ, Shane E, de la Cruz L, Segre CV, Clemens TL, Bilezikian JP, et al. Vitamin D hydroxylation abnormalities in parathyroid hormone secretion and 1,25-dihydroxyvitamin D-3 formation in women with osteoporosis. New Engl J Med. 1989;320:277--281.
78. Wellness Letter, University of California, Berkeley, vol. 24, issue 5, February 2008, entitled Vitamin D: Are You Getting Enough?
79. (Lappe et al., AJCN, Nov 2007.
80. (Autier, P, Gherandin, S, Vitamin D Supplementation and Total Mortality, Arch Intern Med, 2007; 167: 1730-7)
81. (Zhou JCO, 25(5), 479-485, 2007.
82. (Giovannucci- Health Nurses Research Study)
83. (Goodwin et al., ASCO May 15, 2008.
84. Heaney RP. Vitamin D in Health and Disease. Clin J Am Soc Nephrol. 2008 Jun 4.
[Epub ahead of print]
85. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B.
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple
health outcomes. Am J Clin Nutr. 2006;84(1):18-28.
86. (JAMA, National Healthy Examination Survey 2002.)
87. (Finkelstein, EA, Fiebelkorn, IC, Wang, G. National medical spending attributable to
overweight and obesity: How much, and who's paying? Health Affairs 2003;W3;219--226.)
88. Yang Z, Hall AG. The Financial Burden of Overweight and Obesity among Elderly
Americans: The Dynamics of Weight, Longevity, and Health Care Cost. Health Serv Res. 2008 Jun;43(3):849-868.
89. Zhang C, Rexrode KM, van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk
of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in
US women. Circulation. 2008 Apr 1;117(13):1658-67. Epub 2008 Mar 24.
90. AICR Science Now 24 Spring 2008; Doyle et al., CA Cancer J Clin 2006;56:323-353.
91. Larsson SC, Wolk A. Body mass index and risk of multiple myeloma: a meta-
analysis. Int J Cancer. 2007 Dec 1;121(11):2512-2516.
92. (Amling, Relationship Obesity and Cancer Risk. JCO)
93. Demark-Wahnefried W, Moyad MA. Dietary intervention in the management of
prostate cancer. Curr Opin Urol. 2007;17(3):168-174.
94. British Medical Journal reporting both incidence and mortality found that 4% of cancers were associated with obesity and 1% with being overweight
95. Kahn, M. Mediterranean diet may also help stop diabetes (www.ucsfhealth.org/adult/health_library/reuters/2008/05/20080530elin009.html)
96. (Bloomberg, 2/15, Britt)
97. Oh, S. W., Yoon, Y. S., Shin, S. A. Effects of Excess Weight on Cancer Incidence
Depending on Cancer Site and Histologic Findings Among Men: Korean National
Health Insurance Corporation Study. J Clin Oncol. 2005, Jul, 20; 23(21): 4742-4754.
98. (Br Ca Research 2005) breast ca/wt loss
99. (Susanna Larsson, PhD, and Alicja Wolk, DMSc., of the Karolinska Institute) -- hormones/body mass
100. (Reference: Goodwin, P.J., et. al., J Clin Oncol, 2002; 20: 42-51.)
101. McTiernan A. Obesity and cancer: the risks, science, and potential management
strategies. Oncology (Williston Park). 2005;19(7):871-881.
102. Dignam JJ, Wieand K, Johnson KA, Raich P, Anderson SJ, Somkin C. Effects of
obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. Breast Cancer Res Treat. 2005;1-10.
103. Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA.
Body mass and mortality after breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev. 2005;14(8):2009-2014.
104. Berclaz G, Li S, Price KN, Coates AS, Castiglione-Gertsch M, Rudenstam CM, et
al. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. Annal Oncol. 2004;15(6):875-884.
105. Kroenke CH, Chen, WY, Rosner B, Holmes MD. Weight, weight gain, and survival
after breast cancer diagnosis. J Clin Oncol. 2005;23(7):1370-1378.
106. Ryu SY, Kim CB, Nam CM, Park JK, Kim KS, Park J, et al. Is body mass index the
prognostic factor in breast cancer?: a meta-analysis. J Korean Med Sci. 2001;16(5):610-614.
107. Loi S, Milne RL, Friedlander ML, McCredie MR, Giles GG, Hopper JL, et al.
Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(7):1686-1691.
108. Abrahamson, P. E., Gammon, M. D., Lund, M. J., et. Al. General and Abdominal
Obesity and Survival Among Young Women with Breast Cancer. Cancer Epidemiology, Biomarkers, and Prevention, 2006; 15(1): 1871-1877.
109. Amling, C., Riffenburgh, R., H. Sunl. Pathologic Variables and Recurrence Rates
as Related to Obesity and Race in Men with Prostate Cancer Undergoing Radical Prostatectomy. JCO, 22: 439-45, 2004.
110. Bassett WW, Cooperberg MR, Sadetsky N, Silva S, DuChane J, Pasta DJ, Chan JM, Anast JW, Carroll PR, Kane CJ. Impact of obesity on prostate cancer recurrence
after radical prostatectomy: data from CaPSURE. Urology. 2005 Nov;66(5):1060-1605.
111. Eliassen AH, Colditz GA, Rosner B, Willett WC, Hankinson SE. Adult weight
change and risk of postmenopausal breast cancer. JAMA. 2006 Jul 12;296(2):193-201.
112. Nilsen TI, Romundstad PR, Vatten LJ. Recreational physical activity and risk of
prostate cancer: A prospective population-based study in Norway (the HUNT study). Int J Cancer. 2006 Dec 15;119(12):2943-7.
113. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostate
cancer incidence and progression in the health professionals follow-up study. Int J Cancer. 2007;121(7):1571-1578.
114. Milne HM, Wallman KE, Gordon S, Courneya KS. Effects of a combined aerobic
and resistance exercise program in breast cancer survivors: a randomized controlled trial. Breast Cancer Research and Treatment. Volume 108, Number 2 / March, 2008.
115. Barnard RJ, Leung PS, Aronson WJ, Cohen P, Golding LA. A mechanism to explain
how regular exercise might reduce the risk for clinical prostate cancer. Eur J Cancer Prev. 2007;16(5):415-421.
116. Tymchuk CN, Barnard RJ, Heber D, Aronson WJ. Evidence of an inhibitory effect
of diet and exercise on prostate cancer cell growth. J Urol. 2001;166(3):1185-1189.
117. Schneider CM, Hsieh CC, Sprod LK, Carter SD, Hayward R. Cancer treatment-
induced alterations in muscular fitness and quality of life: the role of exercise training. Ann Oncol. 2007;18(12):1957-1962.
|
You are welcome to share this © article with friends, but do not forget to include the author name and web address. Permission needed to use articles on commercial and non commercial websites. Thank you. |
||